View in EDS

Patients with AML and an IDH2-R172 mutation exhibit a unique initial response to intensive chemotherapy induction.

Saved in:
Bibliographic Details
Title: Patients with AML and an IDH2-R172 mutation exhibit a unique initial response to intensive chemotherapy induction.
Authors: Yisraeli Salman M; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Hematology, Shaare Zedek Medical Center, Jerusalem, Israel., Terry AR; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY., Derkach A; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY., Nemirovsky D; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY., Chin KK; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY., Valtis YK; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY., Boussi L; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY., Spivey T; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY., Xiao W; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY., Famulare C; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY., Ciervo J; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY., Rowe JM; Department of Hematology, Shaare Zedek Medical Center, Jerusalem, Israel.; Department of Hematology and BMT, Rambam Health Care Campus and Technion, Israel Institute of Technology, Haifa, Israel., Tallman MS; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY., Stein EM; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Source: Blood advances [Blood Adv] 2025 Jul 08; Vol. 9 (13), pp. 3213-3222.
Publication Type: Journal Article
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40197993
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Patients with AML and an IDH2-R172 mutation exhibit a unique initial response to intensive chemotherapy induction.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Yisraeli+Salman+M%22">Yisraeli Salman M</searchLink>; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Hematology, Shaare Zedek Medical Center, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Terry+AR%22">Terry AR</searchLink>; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Derkach+A%22">Derkach A</searchLink>; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Nemirovsky+D%22">Nemirovsky D</searchLink>; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Chin+KK%22">Chin KK</searchLink>; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Valtis+YK%22">Valtis YK</searchLink>; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Boussi+L%22">Boussi L</searchLink>; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Spivey+T%22">Spivey T</searchLink>; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Xiao+W%22">Xiao W</searchLink>; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Famulare+C%22">Famulare C</searchLink>; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Ciervo+J%22">Ciervo J</searchLink>; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Rowe+JM%22">Rowe JM</searchLink>; Department of Hematology, Shaare Zedek Medical Center, Jerusalem, Israel.; Department of Hematology and BMT, Rambam Health Care Campus and Technion, Israel Institute of Technology, Haifa, Israel.<br /><searchLink fieldCode="AU" term="%22Tallman+MS%22">Tallman MS</searchLink>; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Stein+EM%22">Stein EM</searchLink>; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2025 Jul 08; Vol. 9 (13), pp. 3213-3222.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40197993
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/bloodadvances.2024015324
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3213
    Titles:
      – TitleFull: Patients with AML and an IDH2-R172 mutation exhibit a unique initial response to intensive chemotherapy induction.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Yisraeli Salman M
      – PersonEntity:
          Name:
            NameFull: Terry AR
      – PersonEntity:
          Name:
            NameFull: Derkach A
      – PersonEntity:
          Name:
            NameFull: Nemirovsky D
      – PersonEntity:
          Name:
            NameFull: Chin KK
      – PersonEntity:
          Name:
            NameFull: Valtis YK
      – PersonEntity:
          Name:
            NameFull: Boussi L
      – PersonEntity:
          Name:
            NameFull: Spivey T
      – PersonEntity:
          Name:
            NameFull: Xiao W
      – PersonEntity:
          Name:
            NameFull: Famulare C
      – PersonEntity:
          Name:
            NameFull: Ciervo J
      – PersonEntity:
          Name:
            NameFull: Rowe JM
      – PersonEntity:
          Name:
            NameFull: Tallman MS
      – PersonEntity:
          Name:
            NameFull: Stein EM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 08
              M: 07
              Text: 2025 Jul 08
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2473-9537
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 13
          Titles:
            – TitleFull: Blood advances
              Type: main
ResultId 1